Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy

por Rehman, Hasan, Silk, Ann W., Kane, Michael P., Kaufman, Howard L.
Publicado 2016

Ipilimumab and radiation therapy for melanoma brain metastases

por Silk, Ann W, Bassetti, Michael F, West, Brady T, Tsien, Christina I, Lao, Christopher D
Publicado 2013

Outcomes of palliative radiation therapy for cutaneous squamous cell carcinoma: A retrospective cohort study

por Kim, Emily Y., Granger, Emily E., Schoenfeld, Jonathan D., Silk, Ann W., Margalit, Danielle, Tishler, Roy, Ruiz, Emily S.
Publicado 2023

Real-world outcomes treating patients with advanced cutaneous squamous cell carcinoma with immune checkpoint inhibitors (CPI)

por Hanna, Glenn J., Ruiz, Emily S., LeBoeuf, Nicole R., Thakuria, Manisha, Schmults, Chrysalyne D., Decaprio, James A., Silk, Ann W.
Publicado 2020

Oncolytic Viruses—Natural and Genetically Engineered Cancer Immunotherapies

por Jhawar, Sachin R., Thandoni, Aditya, Bommareddy, Praveen K., Hassan, Suemair, Kohlhapp, Frederick J., Goyal, Sharad, Schenkel, Jason M., Silk, Ann W., Zloza, Andrew
Publicado 2017

Rescue therapy for patients with anti-PD-1-refractory Merkel cell carcinoma: a multicenter, retrospective case series

por LoPiccolo, Jaclyn, Schollenberger, Megan D., Dakhil, Sumia, Rosner, Samuel, Ali, Osama, Sharfman, William H., Silk, Ann W., Bhatia, Shailender, Lipson, Evan J.
Publicado 2019

Leptomeningeal carcinomatosis from a recurrent cutaneous squamous cell carcinoma with perineural invasion in a lung transplant patient

por Granger, Emily E., Silk, Ann W., Sharma, Nirmal S., Groover, Morgan K., Guenette, Jeffrey P., Emerick, Kevin S., Miller, David M., Krause, Katherine A., Ruiz, Emily S.
Publicado 2023

Predictors of immunotherapy benefit in Merkel cell carcinoma

por Kacew, Alec J., Dharaneeswaran, Harita, Starrett, Gabriel J., Thakuria, Manisha, LeBoeuf, Nicole R., Silk, Ann W., DeCaprio, James A., Hanna, Glenn J.
Publicado 2020

The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients

por Wang, Shang-Jui, Jhawar, Sachin R, Rivera-Nunez, Zorimar, Silk, Ann W, Byun, John, Miller, Eric, Blakaj, Dukagjin, Parikh, Rahul R, Weiner, Joseph, Goyal, Sharad
Publicado 2020

Efficacy and safety of high-dose interleukin-2 treatment in patients with a history of brain metastases from renal cell carcinoma

por Chandar, Ashwin, Silk, Ann W, Clark, Joseph I, Daniels, Gregory A, McDermott, David F, Morse, Michael, Wong, Michael KK, Stein, Mark, Mehnert, Janice, Danish, Shabbar, Aung, Sandra, Kaufman, Howard L
Publicado 2015

Effect of cyclo-oxygenase inhibitor use during checkpoint blockade immunotherapy in patients with metastatic melanoma and non-small cell lung cancer

por Wang, Shang-Jui, Khullar, Karishma, Kim, Sinae, Yegya-Raman, Nikhil, Malhotra, Jyoti, Groisberg, Roman, Crayton, Samuel H, Silk, Ann W, Nosher, John L, Gentile, Michael A, Mehnert, Janice M, Jabbour, Salma K
Publicado 2020

A phase Ib study of interleukin-2 plus pembrolizumab for patients with advanced melanoma

por Silk, Ann W., Curti, Brendan, Bryan, Jennifer, Saunders, Tracie, Shih, Weichung, Kane, Michael P., Hannon, Phoebe, Fountain, Christopher, Felcher, Jessica, Zloza, Andrew, Kaufman, Howard L., Mehnert, Janice M., McDermott, David F.
Publicado 2023

A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors

por Silk, Ann W., Saraiya, Biren, Groisberg, Roman, Chan, Nancy, Spencer, Kristen, Girda, Eugenia, Shih, Weichung, Palmeri, Marisa, Saunders, Tracie, Berman, Robert M., Coric, Vlad, Chen, Suzie, Zloza, Andrew, Vieth, Joshua, Mehnert, Janice M., Malhotra, Jyoti
Publicado 2022

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

por Silk, Ann W., Kaufman, Howard L., Curti, Brendan, Mehnert, Janice M., Margolin, Kim, McDermott, David, Clark, Joseph, Newman, Jenna, Bommareddy, Praveen K., Denzin, Lisa, Najmi, Saltanat, Haider, Azra, Shih, Weichung, Kane, Michael P., Zloza, Andrew
Publicado 2020

A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850

por Spencer, Kristen R., Portal, Daniella E., Aisner, Joseph, Stein, Mark N., Malhotra, Jyoti, Shih, Weichung, Chan, Nancy, Silk, Ann W., Ganesan, Shridar, Goodin, Susan, Gounder, Murugesan, Lin, Hongxia, Li, Jiadong, Cerchio, Robert, Marinaro, Christina, Chen, Suzie, Mehnert, Janice M.
Publicado 2023

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition

por Buchbinder, Elizabeth I., Dutcher, Janice P., Daniels, Gregory A., Curti, Brendan D., Patel, Sapna P., Holtan, Shernan G., Miletello, Gerald P., Fishman, Mayer N., Gonzalez, Rene, Clark, Joseph I., Richart, John M., Lao, Christopher D., Tykodi, Scott S., Silk, Ann W., McDermott, David F.
Publicado 2019

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of nonmelanoma skin cancer

por Silk, Ann W, Barker, Christopher A, Bhatia, Shailender, Bollin, Kathryn B, Chandra, Sunandana, Eroglu, Zeynep, Gastman, Brian R, Kendra, Kari L, Kluger, Harriet, Lipson, Evan J, Madden, Kathleen, Miller, David M, Nghiem, Paul, Pavlick, Anna C, Puzanov, Igor, Rabinowits, Guilherme, Ruiz, Emily S, Sondak, Vernon K, Tavss, Edward A, Tetzlaff, Michael T, Brownell, Isaac
Publicado 2022

A phase 1b single-arm trial of intratumoral oncolytic virus V937 in combination with pembrolizumab in patients with advanced melanoma: results from the CAPRA study

por Silk, Ann W., O’Day, Steven J., Kaufman, Howard L., Bryan, Jennifer, Norrell, Jacqueline T., Imbergamo, Casey, Portal, Daniella, Zambrano-Acosta, Edwin, Palmeri, Marisa, Fein, Seymour, Wu, Cai, Guerreiro, Leslie, Medina, Daniel, Bommareddy, Praveen K., Zloza, Andrew, Fox, Bernard A., Ballesteros-Merino, Carmen, Ren, Yixin, Shafren, Darren, Grose, Mark, Vieth, Joshua A., Mehnert, Janice M.
Publicado 2022

Combination oncolytic virus, radiation therapy, and immune checkpoint inhibitor treatment in anti-PD-1-refractory cancer

por Jhawar, Sachin R, Wang, Shang-Jui, Thandoni, Aditya, Bommareddy, Praveen K, Newman, Jenna H, Marzo, Amanda L, Kuzel, Timothy M, Gupta, Vineet, Reiser, Jochen, Daniels, Preston, Schiff, Devora, Mitchell, Darrion, LeBoeuf, Nicole R, Simmons, Christopher, Goyal, Sharad, Lasfar, Ahmed, Guevara-Patino, Jose A, Haffty, Bruce G, Kaufman, Howard L, Silk, Ann W, Zloza, Andrew
Publicado 2023

BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced BRAFV600-mutant Melanoma

por Mehnert, Janice M., Mitchell, Tara C., Huang, Alexander C., Aleman, Tomas S., Kim, Benjamin J., Schuchter, Lynn M., Linette, Gerald P., Karakousis, Giorgos C., Mitnick, Sheryl, Giles, Lydia, Carberry, Mary, Frey, Noelle, Kossenkov, Andrew, Groisberg, Roman, Hernandez-Aya, Leonel F., Ansstas, George, Silk, Ann W., Chandra, Sunandana, Sosman, Jeffrey A., Gimotty, Phyllis A., Mick, Rosemarie, Amaravadi, Ravi K.
Publicado 2022